Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.